|
|
|
|
| LEADER |
01000caa a2200265 4500 |
| 001 |
OLC1978312946 |
| 003 |
DE-627 |
| 005 |
20230714201247.0 |
| 007 |
tu |
| 008 |
160719s2016 xx ||||| 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.bmcl.2016.05.071
|2 doi
|
| 028 |
5 |
2 |
|a PQ20160719
|
| 035 |
|
|
|a (DE-627)OLC1978312946
|
| 035 |
|
|
|a (DE-599)GBVOLC1978312946
|
| 035 |
|
|
|a (PRQ)c677-f0e8e4e5939ba1aceb2a5a8dd561c9927467038c36fc223ccc6312d35d49cf170
|
| 035 |
|
|
|a (KEY)0209141020160000000000000000evaluationofbisbenzamidinesasinhibitorsformatripta
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 540
|a 610
|q DE-600
|
| 084 |
|
|
|a PHARM
|2 fid
|
| 084 |
|
|
|a VA 2620
|q AVZ
|2 rvk
|
| 100 |
1 |
|
|a Beckmann, Anna-Madeleine
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Evaluation of bisbenzamidines as inhibitors for matriptase-2
|
| 264 |
|
1 |
|c 2016
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Gilberg, Erik
|4 oth
|
| 700 |
1 |
|
|a Gattner, Susanne
|4 oth
|
| 700 |
1 |
|
|a Huang, Tien L
|4 oth
|
| 700 |
1 |
|
|a Vanden Eynde, Jean Jacques
|4 oth
|
| 700 |
1 |
|
|a Mayence, Annie
|4 oth
|
| 700 |
1 |
|
|a Bajorath, Jürgen
|4 oth
|
| 700 |
1 |
|
|a Stirnberg, Marit
|4 oth
|
| 700 |
1 |
|
|a Gütschow, Michael
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Bioorganic & medicinal chemistry letters
|d Amsterdam [u.a.] : Elsevier, 1991
|g (2016)
|w (DE-627)130952400
|w (DE-600)1063195-1
|w (DE-576)025097946
|x 0960-894X
|7 nnns
|
| 773 |
1 |
8 |
|g year:2016
|
| 856 |
4 |
1 |
|u http://dx.doi.org/10.1016/j.bmcl.2016.05.071
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a FID-PHARM
|
| 912 |
|
|
|a SSG-OLC-CHE
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_4305
|
| 936 |
r |
v |
|a VA 2620
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2016
|
